ArticleAmerican journal of cancer research2021

PD-1 antibody camrelizumab for Epstein-Barr virus-positive metastatic gastric cancer: a single-arm, open-label, phase 2 trial.

Yu-Ting Sun et al.PubMed ↗Full text ↗

No numbers read from the abstract.